These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6498125)

  • 1. Peripheral vasomotor control and menopausal flushing--a preliminary report.
    Brincat M; de Trafford JC; Lafferty K; Studd JW
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1107-10. PubMed ID: 6498125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogen addition during oestrogen replacement therapy--effects on vasomotor symptoms and mood.
    Holst J; Bäckström T; Hammarbäck S; von Schoultz B
    Maturitas; 1989 Mar; 11(1):13-20. PubMed ID: 2725334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation of physiological changes to subjective symptoms in postmenopausal women with and without hot flushes.
    Mashchak CA; Kletzky OA; Artal R; Mishell DR
    Maturitas; 1984 Dec; 6(4):301-8. PubMed ID: 6533433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New data on the physiology and treatment of vasomotor menopausal flushing].
    Buvat J; Buvat-Herbaut M
    LARC Med; 1983 Apr; 3(4):236, 241, 243-5. PubMed ID: 6137742
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral blood flow in menopausal women who have hot flushes and in those who do not.
    Ginsburg J; Hardiman P; O'Reilly B
    BMJ; 1989 Jun; 298(6686):1488-90. PubMed ID: 2503082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal flushing: does oestrogen therapy make sense?
    Mulley G; Mitchell JR
    Lancet; 1976 Jun; 1(7974):1397-9. PubMed ID: 59028
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiology and treatment of hot flushes.
    Ravnikar V
    Obstet Gynecol; 1990 Apr; 75(4 Suppl):3S-8S; discussion 15S-17S. PubMed ID: 2179788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is estrogen replacement therapy necessary?
    Hammond CB; Nachtigall LE
    J Reprod Med; 1985 Oct; 30(10 Suppl):797-801. PubMed ID: 4078811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal hot flushes and night sweats: where are we now?
    Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
    Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and endocrine studies in menopausal women after estradiol pellet implantation.
    Nagamani M; Lin TJ; McDonough PG; Watatani H; McPherson JC; Mahesh VB
    Obstet Gynecol; 1977 Nov; 50(5):541-7. PubMed ID: 909658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2004 Jan; 87(1):33-40. PubMed ID: 14971532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis.
    Mohammady M; Janani L; Jahanfar S; Mousavi MS
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():295-302. PubMed ID: 30056356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of skin surface texture by topical estradiol treatment in climacteric women.
    Masuda Y; Hirao T; Mizunuma H
    J Dermatolog Treat; 2013 Aug; 24(4):312-7. PubMed ID: 22103800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.
    Tane K; Egawa C; Takao S; Yamagami K; Miyashita M; Baba M; Ichii S; Konishi M; Kikawa Y; Minohata J; Okuno T; Miyauchi K; Wakita K; Suwa H; Hashimoto T; Nishino M; Matsumoto T; Hidaka T; Konishi Y; Sakoda Y; Miya A; Kishimoto M; Nishikawa H; Kono S; Kokufu I; Sakita I; Kitatsuji K; Oh K; Akazawa K; Miyoshi Y
    Breast Cancer; 2017 Jul; 24(4):528-534. PubMed ID: 27730528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopause and estrogen replacement therapy.
    Stuenkel CA
    Psychiatr Clin North Am; 1989 Mar; 12(1):133-52. PubMed ID: 2652104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment.
    Rapkin AJ
    Am J Obstet Gynecol; 2007 Feb; 196(2):97-106. PubMed ID: 17306645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH
    Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.